1. United States
2. N.D.
3. Letter

The Food and Drug Administration (FDA) plays a crucial role in ensuring the safety of our food supply. However, recent staffing cuts and the decision to outsource key support roles to private contractors raise significant concerns about the agency's ability to fulfill this vital responsibility effectively. The COVID-19 pandemic has already strained the FDA's inspection workforce, with many experienced employees retiring or resigning. Reducing staff further, particularly in roles that directly support inspectors and testing laboratories, will only exacerbate these challenges. Private contractors may lack the specialized expertise and institutional knowledge necessary to navigate the complexities of FDA operations and international inspections. Relying on private companies is also likely to be more costly in the long run compared to investing in the FDA's own workforce. Contractors may prioritize profits over public health, leading to potential conflicts of interest. The FDA should strive to create a supportive work environment that attracts and retains dedicated public servants committed to protecting consumer safety. I urge you to reconsider these staffing cuts and the outsourcing plans. Instead, focus on improving working conditions within the FDA, streamlining hiring processes, and allocating sufficient resources to bolster the agency's inspection and testing capabilities. A well-funded and properly staffed FDA is essential to safeguarding the integrity of our nation's food supply and ensuring the public's trust in the agency's oversight.